MedPath

Does Personality Predict Patient Adherence, Health Behaviors, and Weight Loss Outcomes During the Latino Crossover Semaglutide Study (LCSS)? (Story-LCSS Project)

Active, not recruiting
Conditions
Obesity
Body Weight Changes
Interventions
Behavioral: Voice data
Registration Number
NCT05622045
Lead Sponsor
Loma Linda University
Brief Summary

The goal of this observational study is to learn about the personality attributes and values of people living with obesity that are part of the Latino community, and how these personality attributes and values can help to predict success during a weight loss program.

The main questions it aims to answer are:

* What are the personality attributes and values of people living with obesity that sign up to the LCSS-Latino Crossover Semaglutide Study trial?

* Can behavioral artificial intelligence (a computer formula) predict which patients will complete the LCSS-Latino Crossover Semaglutide Study trial?

* How do behavioral artificial Intelligence predictions (a computer formula) compare to clinician predictions of patient success?

* Can behavioral artificial intelligence (a computer formula) predict patient weight loss, calorie consumption and physical activity levels during the LCSS-Latino Crossover Semaglutide Study trial? Participants will be recorded in English and Spanish while responding to a question regarding participation in a weight loss study.

Detailed Description

Not available

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
59
Inclusion Criteria
  • Participation in the LCSS-Latino Crossover Semaglutide Study
Exclusion Criteria
  • Not a participant of the LCSS-Latino Crossover Semaglutide Study at the point of data collection

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Story-LCSSVoice data-
Primary Outcome Measures
NameTimeMethod
Predicated patient physical activity levelThe voice data measurement will take at baseline and take about 10-15 minutes for collection to take place.

Predicted patient physical activity level as determined by Scaled Insights Behavioural Artificial Intelligence based on subject voice data. Predicted physical activity will be compared to the physical activity measured in a separate clinical trial \[Latino Crossover Semaglutide Study (LCSS) NCT05087342\]. Similar physical activity level values between the predicted and measured outcomes will indicate that the Scaled Insights Behavioural Artificial Intelligence is good predictor.

Predicted patient weight change successThe voice data measurement will take place at baseline and take about 10-15 minutes for collection to take place.

Predicted patient weight change as determined by Scaled Insights Behavioural Artificial Intelligence based on subject voice data. Weight loss exceeding 5-10 pounds over 6 months will be considered to be successful. Predicted weight change will be compared to the weight change measured in a separate clinical trial \[Latino Crossover Semaglutide Study (LCSS) NCT05087342\]. Similar weight change values between the predicted and measured outcomes will indicate that the Scaled Insights Behavioural Artificial Intelligence is good predictor.

Clinician predictionsThe clinician judgement will be measured during the second month of the subject's weight loss study.

Clinician (physician) judgement of patient weight loss success during a weight loss study.

Predicated patient calorie intakeThe voice data measurement will take place during the subject's initial clinic visit and take about 10-15 minutes for collection to take place.

Predicted patient calorie intake as determined by Scaled Insights Behavioural Artificial Intelligence based on subject voice data. Predicted calorie intake will be compared to the calorie intake measured in a separate clinical trial \[Latino Crossover Semaglutide Study (LCSS) NCT05087342\]. Similar calorie values between the predicted and measured outcomes will indicate that the Scaled Insights Behavioural Artificial Intelligence is good predictor.

Secondary Outcome Measures
NameTimeMethod
Personality attributes and valuesThe voice data measurement will take place at baseline and take about 10-15 minutes for collection to take place.

Extrapolated personality attributes and values as determined by Scaled Insights Behavioural Artificial Intelligence based on subject voice data. These are qualitative non-numerical descriptors.

Predicted patient attrition rateThe voice data measurement will take place at baseline and take about 10-15 minutes for collection to take place.

Predicted patient attrition rate from the weight loss study as determined by Scaled Insights Behavioural Artificial Intelligence based on subject voice data. Predicted patient attrition rate will be compared to the attrition rate occurring during the weight loss study. Similar attrition rates between the predicted and actual rates will indicate that the Scaled Insights Behavioural Artificial Intelligence is good predictor.

Trial Locations

Locations (1)

Nutrition Research Center, School of Public Health, Loma Linda University

🇺🇸

Loma Linda, California, United States

© Copyright 2025. All Rights Reserved by MedPath